the effects produced by bzp are comparable to those produced by amphetamine adverse effects have been reported following its use including acute psychosis renal toxicity and seizures no deaths have been reported following a sole ingestion of bzp although there have been at least two deaths from the combination of bzp and mdma its sale is banned in several countries including australia canada new zealand the united states the republic of ireland the united kingdom bulgaria romania and other parts of europe it is often claimed that bzp was originally synthesized as a potential antihelminthic anti parasitic agent for use in farm animals however there are some references to bzp in medical literature that predate interest in piperazines as antihelminthics even so the majority of the early work with the piperazines were investigations into their potential use as antihelminthics with the earliest clinical trials in the literature relating to piperazine being articles in the british medical journal in the 1950s it was discovered that bzp had side effects and was largely abandoned as a worm treatment it next appears in the literature in the 1970s when it was investigated as a potential antidepressant medication but rejected when research reported that